Short-term β-amyloid vaccinations do not improve cognitive performance in cognitively impaired APP+PS1 mice.
- 1 January 2003
- journal article
- research article
- Published by American Psychological Association (APA) in Behavioral Neuroscience
- Vol. 117 (3) , 478-484
- https://doi.org/10.1037/0735-7044.117.3.478
Abstract
Prior work demonstrated that beta-amyloid (A beta) immunotherapy for 8 months prevented cognitive impairment in 16-month-old APP + PS1 transgenic mice. In the present study, 4 immunizations administered biweekly to cognitively impaired 16-month-old transgenic mice could not reverse deficits in working memory or reference memory in the radial arm water maze or in visual platform recognition, possibly because of inadequate antibody exposure. Nontransgenic mice showed cognitive savings between the 16- and 18-month test periods, but the transgenic groups did not. These results suggest that a longer period of active immunotherapy, or passive immunization, may be required to provide sufficient antibody titers to improve cognition in older transgenic mice. A beta-based immunotherapy for Alzheimer's disease will likely be more successful prophylactically than therapeutically.Keywords
This publication has 22 references indexed in Scilit:
- Immunization reverses memory deficits without reducing brain Aβ burden in Alzheimer's disease modelNature Neuroscience, 2002
- Behavioral Assessment of Alzheimer's Transgenic Mice Following Long-Term Aβ Vaccination: Task Specificity and Correlations between Aβ Deposition and Spatial MemoryDNA and Cell Biology, 2001
- Number of Aβ Inoculations in APP+PS1 Transgenic Mice Influences Antibody Titers, Microglial Activation, and Congophilic Plaque LevelsDNA and Cell Biology, 2001
- Duration and Specificity of Humoral Immune Responses in Mice Vaccinated with the Alzheimer's Disease-Associated β-Amyloid 1-42 PeptideDNA and Cell Biology, 2001
- Immunization with a Nontoxic/Nonfibrillar Amyloid-β Homologous Peptide Reduces Alzheimer's Disease-Associated Pathology in Transgenic MiceThe American Journal of Pathology, 2001
- Peripheral anti-Aβ antibody alters CNS and plasma Aβ clearance and decreases brain Aβ burden in a mouse model of Alzheimer's diseaseProceedings of the National Academy of Sciences, 2001
- Correlation between cognitive deficits and Aβ deposits in transgenic APP+PS1 miceNeurobiology of Aging, 2001
- Disaggregation of Alzheimer β-amyloid by site-directed mAbProceedings of the National Academy of Sciences, 1997
- Monoclonal antibodies inhibit in vitro fibrillar aggregation of the Alzheimer beta-amyloid peptide.Proceedings of the National Academy of Sciences, 1996
- A behavioural analysis of rats with damage to the medial prefrontal cortex using the morris water maze: evidence for behavioural flexibility, but not for impaired spatial navigationBrain Research, 1994